Vimarsana
Biggest News Aggregation in the World

Page 2 - Bart Leroy News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Bart Leroy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Bart Leroy Today - Breaking & Trending Today

ProQR Announces Top-Line Results from Phase 2/3 Illuminate Trial of Sepofarsen in CEP290-mediated LCA10 - Vimarsana News

ProQR Announces Top-Line Results from Phase 2/3 Illuminate Trial of Sepofarsen in CEP290-mediated LCA10

ProQR Announces Top-Line Results from Phase 2/3 Illuminate Trial of Sepofarsen in CEP290-mediated LCA10Study did not meet primary endpoint nor notable secondary endpoints – no benefit observed in either treatment arm versus shamAdditional analyses to be conducted and presented at a future medical congressSepof...

IVERIC bio, Inc. (ISEE) Q1 2021 Earnings Call Transcript - Vimarsana News

IVERIC bio, Inc. (ISEE) Q1 2021 Earnings Call Transcript

Operator Good morning, and welcome to the Iveric Bio first-quarter 2021 earnings conference call. [Operator instructions] Please note this call is being recorded. I would now like to turn the conference over to Kathy Galante, senior vice president, investor relations. Please go ahead. Kathy Galante -- Senior Vice President, Investor Relations Good morning, and welcome to Iveric Bio's conference call. Representing Iveric Bio today are Glenn Sblendorio, chief executive officer; Pravin Dugel, president; David Carroll, chief financial officer; Dhaval Desai, chief development officer; Abraham Sca...

Source: fool.com
Renowned Pioneers in Ophthalmology Join SparingVision's Scientific Advisory Board - Vimarsana News

Renowned Pioneers in Ophthalmology Join SparingVision's Scientific Advisory Board

Renowned Pioneers in Ophthalmology Join SparingVision's Scientific Advisory Board Development of lead asset SPVN06 to further benefit from high-level Clinical Advisory Board Paris, January 29, 2021 - SparingVision (the "Company"), a genomic medicine company developing vision saving treatments for ocular diseases, today announces the strengthening of its Scientific Advisory Board ("SAB") with the appointment of internationally renowned ophthalmology pioneers Dr. Paul A. Sieving, Professor of University of California Davis School of Medicine and the former Director of the US National Eye Insti...